Loading organizations...
PHC Holdings Corporation provides comprehensive products and services spanning diabetes management, healthcare solutions, diagnostics, and life sciences globally. The company integrates advanced digital solutions with its expertise in precision technology, which has been honed over decades, to deliver sophisticated devices and services. These offerings are designed to advance basic research, enhance diagnostic capabilities, and improve medical treatment outcomes across various healthcare segments.
Established in 1948 and headquartered in Chiyoda, Japan, PHC Holdings Corporation has a long history rooted in the medical and healthcare sector. The company’s trajectory reflects a sustained commitment to developing high-quality, precise technology in response to evolving healthcare needs. This enduring focus on innovation and technical excellence has shaped its strategic direction and product development over many years.
The company serves a broad customer base, including patients, healthcare professionals, and researchers in over 125 countries. PHC Holdings Corporation's long-term vision is to be a leader in precision technology, powering the future of healthcare by creating products that support individuals in leading healthier and more active lives. It maintains a forward-looking perspective, continuously working to improve health and wellbeing through technological advancement.
Key people at PHC Holdings Corporation.
PHC Holdings Corporation has 1 tracked investment across 1 company. The latest tracked deal is $54.4M Debt / Series D in Lunaphore in March 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 24, 2023 | Lunaphore | $54.4M Debt / Series D | Dominik Sauter | Norgine Ventures, Occident, Redalpine, Swiss Entrepreneurs Fund |
Key people at PHC Holdings Corporation.